Author

D. Peterhoff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Biophysics· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 4 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Assay:protein sequence· 1

Frequent Co-Authors

R. Wagner· 3 shared A. Gessner· 2 shared S. Blaas· 2 shared A. Ensser· 1 shared A. J. Walter· 1 shared A. Mohr· 1 shared A. S. Peter· 1 shared B. Correia· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

R. Wagner

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

IgG4 serum levels are not elevated in cases of Post-COVID syndrome

J. Abel, A. J. Walter, V. Glueck, C. L. Magnus, T. Glueck, P. Schuster, S. Blaas, I. Montanari, M. Koller, A. Mohr, T. Hinterberger, B. Salzberger, K. Renner, M. Mack, R. Bals, , D. Peterhoff

The paper compares IgG subtypes in Post-COVID patients and controls, finding no elevation in IgG4 but reduced IgG2, suggesting potential role of IgG2 in Post-COVID syndrome.

bioRxiv · Mar 1, 2023 · PreprintImmunology

Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from cystic fibrosis patients

J. M. Holzinger, M. Toelge, M. Werner, K. U. Ederer, H. I. Siegmund, D. Peterhoff, S. Blaas, N. Gisch, C. Brochhausen-Delius, A. Gessner, S. Bülow

The paper shows that scorpionfish-derived BPI (scoBPI) is effective against drug-resistant Pseudomonas aeruginosa in CF patients, even when human BPI is neutralized by autoantibodies.

bioRxiv · Feb 19, 2023Microbiology

A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model

A. S. Peter, E. Roth, S. R. Schulz, K. Fraedrich, T. Steinmetz, D. Damm, M. Hauke, E. Richel, S. Mueller-Schmucker, K. Habenicht, V. Eberlein, L. Issmail, N. Uhlig, S. Dolles, E. Gruner, , H.-M. Jack

The paper identifies two clusters of non-competing neutralizing antibodies against SARS-CoV-2 that protect mice from infection and weight loss.

bioRxiv · Apr 16, 2021 · PreprintImmunology

Multi-parameter formulation development for an HIV-vaccine protein with direct validation of epitope binding integrity and stoichiometry

C. Popp, P. Schramm, R. Wagner, D. Peterhoff, C. Battle, C. Kleusch, M. G. Plach

The paper develops a multi-parameter formulation for an HIV vaccine protein, validating epitope binding and stoichiometry using advanced biophysical tools.

bioRxiv · Nov 30, 2020 · PreprintBiophysics

Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike protein

D. Lainscek, T. Fink, V. Forstneric, I. Hafner-Bratkovic, S. Orehek, Z. Strmsek, M. Mancek Keber, P. Pecan, H. Esih, S. Malensek, J. Aupic, P. Dekleva, T. Plaper, S. Vidmar, L. Kadunc, , R. Jerala

This study evaluates DNA vaccines with RBD domains scaffolded by different peptides, finding that the β-annulus scaffold elicits the strongest immune response in mice.

bioRxiv · Aug 28, 2020 · PreprintImmunology